Characteristics and predictors of gastric cancer after Helicobacter pylori eradication

doi:10.3748/wjg.v24.i20.2163

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 20

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16799)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

1412

WORD

465

HTML

10452

Figures (1-2)

628

Tables (1-2)

525

Sum=13482

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1244

Download

2069

Sum=3313

May 28, 2018 (publication date) through Mar 5, 2026

Times Cited of This Article

Times Cited (51)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Gastroenterol. May 28, 2018; 24(20): 2163-2172
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2163

Characteristics and predictors of gastric cancer after Helicobacter pylori eradication

Satoki Shichijo, Yoshihiro Hirata

Satoki Shichijo, Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka 541-8567, Japan

Yoshihiro Hirata, Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan

Author contributions: Shichijo S drafted the article; and Hirata Y critically revised and approved the final article.

Supported by (partly) JSPS KAKENHI, No. 17K09346 and No. 16K09279.

Conflict-of-interest statement: The authors declare that no competing interests exist.

Correspondence to: Yoshihiro Hirata, MD, PhD, Associate Professor, Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. yohirata@ims.u-tokyo.ac.jp

Telephone: +81-3-64092335 Fax: +81-3-64092336

Received: March 27, 2018
Peer-review started: March 28, 2018
First decision: April 19, 2018
Revised: May 4, 2018
Accepted: May 18, 2018
Article in press: May 18, 2018
Published online: May 28, 2018
Processing time: 62 Days and 9.4 Hours

Core Tip

Core tip: Gastric cancer develops even after successful Helicobacter pylori (H. pylori) eradication therapy. With the prevalence of eradication therapy, occurrence rates of gastric cancer detected after eradication are increasing and this is becoming an important clinical issue. We review the characteristics and predictors of primary gastric cancer after H. pylori eradication, and discuss the risk stratification of gastric cancer after eradication.